Insulin TDD was reduced in five participants, by an average of 16.4 units
The evolving landscape underscores the need for clear enforcement, robust pharmacovigilance, and strategic engagement to protect patient safety and preserve brand integrity
In LEADER, there was a higher, albeit non-significant, rate of adverse retinal events with liraglutide compared with placebo (HR 1.15, 95% CI 0.871.52
Conditions like neurofibromatosis type 2 are associated with higher tumor susceptibility
Now, this study not only reinforces the evidence base for telehealth, but shows that Ro can help patients reach the kinds of outcomes seen in clinical trials," said Dr
We will get in touch with you to answer any questions you have